emerg
need
costeffect
treatment
worldwid
repurpos
develop
drug
exist
market
approv
diseas
new
diseas
valid
option
although
strateg
mine
electron
health
record
produc
realworld
evid
inform
drug
repurpos
use
omic
data
drug
diseas
knowledg
base
protein
interact
databas
transcript
factor
explor
structur
integr
exist
data
framework
drug
repurpos
facilit
decis
make
abil
forese
need
integr
new
data
type
produc
emerg
technolog
enabl
data
connect
context
human
biolog
target
diseas
well
use
exist
crucial
qualiti
data
approv
drug
catapult
number
drug
success
repurpos
howev
translat
pharmacodynam
databas
model
inform
across
human
biolog
context
host
factor
lack
critic
need
drug
repurpos
improv
global
public
health
especi
effort
combat
neglect
tropic
diseas
well
emerg
infecti
diseas
zika
ebola
viru
drug
repurpos
reposit
defin
develop
drug
exist
market
approv
diseas
new
diseas
observ
treatmentrel
advers
reaction
drug
develop
led
reposit
differ
indic
case
includ
antihypertens
drug
minoxidil
repurpos
alopecia
sildenafil
erectil
dysfunct
success
achiev
drug
repurpos
drug
fda
ongo
effort
made
clinicaltrialsgov
use
key
word
drug
repurpos
drug
reposit
hand
studi
found
variou
stage
clinic
trial
http
clinicaltrialsgov
howev
still
unmet
medic
need
communic
diseas
cd
noncommunic
diseas
ncd
worldwid
creativ
new
measur
need
effort
drug
repurpos
mani
neglect
tropic
diseas
preval
poor
countri
affect
million
peopl
occasion
caus
deadli
outbreak
invok
global
panic
inflict
harm
global
economi
wellb
recent
outbreak
deadli
ebola
viru
diseas
evd
current
spread
zika
viru
infect
caus
birth
babi
microcephali
caus
global
distress
addit
million
peopl
famili
struggl
ncd
includ
mental
ill
develop
underdevelop
countri
tremend
need
costeffect
medic
treat
emerg
diseas
reduc
global
health
burden
advanc
molecular
biolog
big
data
transcriptom
proteom
phosphoproteom
function
profil
thousand
drug
chemic
across
mani
cell
type
immort
cell
line
primari
cell
stem
cell
stem
cellsederiv
cell
tissu
construct
enabl
us
realist
captur
mode
action
drug
diseas
biolog
furthermor
electron
health
record
ehr
claim
databas
aggreg
across
institut
observ
studi
discov
novel
new
therapeut
effect
drug
drug
repurpos
treat
diseas
unmet
medic
need
effici
navig
abund
biomed
data
accumul
life
scienc
knowledg
one
address
follow
key
question
costeffect
repurpos
drug
new
indic
data
sourc
avail
realworld
medic
evid
biomed
clue
molecular
level
translat
data
leverag
establish
biolog
linkag
molecular
level
organ
phenotyp
system
pharmacolog
model
construct
assess
dose
respons
relationship
facilit
design
conduct
clinic
trial
brief
forefront
tremend
opportun
use
omic
imag
phenotyp
data
knowledg
divers
natur
discov
new
mode
action
drug
repurpos
therebi
aid
global
effort
combat
diseas
consid
volum
type
data
accumul
knowledg
technolog
system
pharmacolog
analysi
model
pharmaceut
research
develop
qualiti
translat
databas
pharmacodynam
approv
drug
need
databas
support
crosshierarchi
translat
molecularlevel
inform
drug
action
diseas
biolog
macrolevel
phenotyp
function
measur
includ
natur
histori
diseas
marker
diseas
progress
respons
drug
therebi
acceler
success
drug
repurpos
progress
made
repurpos
drug
new
indic
evidenc
number
drug
approv
rare
diseas
close
drug
product
one
approv
orphan
diseas
well
least
market
approv
common
diseas
indic
drug
product
market
approv
common
rare
diseas
indic
effort
drug
repurpos
continu
made
demonstr
list
ongo
drugrepurpos
clinic
trial
http
clinicaltrialsgov
summar
tabl
addit
nation
center
advanc
translat
scienc
provid
fund
support
earlystag
latestag
drugrepurpos
effort
along
institut
research
effort
drug
repurpos
http
ongo
clinic
trial
clinicaltrialsgov
either
focus
cancer
smoke
abstin
alcohol
abus
light
global
economi
health
burden
effort
repurpos
drug
known
safeti
profil
need
follow
urgent
medic
need
reduc
global
health
burden
highlight
accord
world
health
organ
report
publish
among
major
infecti
diseas
affect
global
health
hivaid
caus
million
death
tuberculosi
million
death
malaria
million
death
number
tuberculosi
case
million
million
men
million
women
million
children
notabl
infecti
diseas
outbreak
recent
year
caus
global
panic
disrupt
global
travel
trade
includ
deadli
evd
middl
east
respiratori
syndrom
sever
acut
respiratori
syndrom
particularli
concern
zika
viru
diseas
associ
birth
defect
infecti
diseas
caus
high
mortal
seriou
side
effect
irrevers
birth
defect
due
lack
effect
treatment
emerg
infecti
diseas
local
outbreak
includ
measl
sinc
pandem
influenza
caus
swine
flu
cholera
chikyngunya
sinc
accord
http
wwwwhointneglecteddiseasesdiseasesen
billion
peopl
across
countri
affect
neglect
tropic
diseas
ncd
caus
death
worldwid
led
death
age
less
year
compar
cd
accord
statist
cardiovascular
diseas
caus
million
death
chronic
respiratori
diseas
million
death
cancer
million
death
diabet
million
death
ncd
rest
econom
social
global
infecti
diseas
advers
impact
ncd
global
issu
tremend
need
costeffect
medicin
reduc
global
health
burden
repurpos
drug
known
characterist
safeti
profil
constitut
part
solut
advanc
biomed
comput
technolog
led
product
tremend
volum
qualiti
data
made
avail
big
data
accumul
knowledg
divers
organ
platform
pharmacokinet
pk
characterist
drug
market
approv
avail
multipl
data
sourc
drug
fda
dailym
pubm
pharmacogenom
drug
human
genet
hapmap
avail
pubm
curat
inform
pharmgkb
http
wwwpharmgkborg
respect
explor
person
drug
repurpos
side
horizon
ehr
emerg
resourc
evalu
effect
safeti
therapeut
importantli
new
therapeut
use
medic
record
digit
era
offer
opportun
use
realworld
evid
discov
new
novel
therapeut
effect
approv
drug
exampl
metformin
drug
treat
type
ii
diabet
reportedli
associ
lower
risk
colon
pancreat
cancer
unit
kingdom
reduc
preval
malign
germani
well
increas
surviv
benefit
cancer
patient
mechanist
vitro
inhibit
mitochondri
respiratori
complex
reportedli
plausibl
mechan
antineoplast
effect
anoth
exampl
statin
statin
use
associ
reduc
incid
uveiti
statin
reportedli
possess
antiinflammatori
effect
reduc
use
oral
steroid
inflammatori
bowel
diseas
patient
studi
recent
patient
prescrib
artesunateamodiaquin
malaria
reportedli
lower
mortal
rate
evd
prescrib
regimen
suggest
artesun
amodiaquin
warrant
investig
therapeut
benefit
treat
evd
mine
ehr
identifi
terbutalin
approv
treat
asthma
candid
amyotroph
later
sclerosi
support
vivo
effect
zebrafish
aforement
exampl
illustr
mine
realworld
evid
worthwhil
drug
repurpos
comput
method
appli
gene
express
data
drug
repurpos
failur
topiram
repurpos
inflammatori
bowel
diseas
subsequ
disappoint
therapeut
benefit
topiram
reduc
irrit
bowel
syndrom
flare
point
transcriptom
alon
unveil
drug
human
biolog
interact
comput
show
pharmacolog
target
drug
associ
treatmentrel
neuropathi
link
via
proteinprotein
interact
small
list
statist
signific
transcript
factor
laid
foundat
latter
work
comput
signal
pathway
drug
drug
target
differenti
perturb
gene
abl
link
druginduc
differenti
express
gene
drug
target
use
integ
linear
program
across
prior
knowledg
protein
interact
network
transcript
factor
drug
target
protein
critic
need
use
transcript
factor
linker
establish
comput
connect
mrna
intracellular
biolog
protein
network
context
understand
effect
drug
big
data
vitro
omic
data
realworld
ehr
knowledg
base
biolog
protein
interact
signal
propag
provid
rich
inform
drug
repurpos
integr
util
variou
data
type
would
help
us
understand
biolog
connect
context
human
biolog
perturb
drug
would
crucial
step
repurpos
drug
polypharmaci
long
medic
practic
use
strateg
use
combin
product
combat
diseas
hiv
diseas
repurpos
approv
drug
combin
combat
viral
diseas
block
key
point
life
cycl
viru
use
host
cell
apparatu
reason
approach
look
forward
potenti
strategi
drug
repurpos
identifi
new
novel
target
approv
drug
identifi
combin
product
use
target
diseas
shown
figur
identifi
potent
combin
approv
drug
treat
diseas
viabl
option
exampl
combin
statin
topoisomeras
inhibitor
reportedli
enhanc
proapoptot
activ
latter
glioblastoma
match
drug
drug
pair
diseas
complet
one
could
use
histor
biopharmaceut
clinic
pharmacolog
data
conduct
system
pharmacolog
model
optim
dose
regimen
studi
clinic
trial
new
indic
fig
ad
relev
biomark
match
model
could
make
model
power
use
discuss
follow
highlight
type
data
use
drug
repurpos
shown
figur
potenti
candid
accumul
data
biopharmaceut
clinic
pharmacolog
characterist
physicochem
properti
formul
dose
regimen
clinic
pharmacolog
characterist
includ
pharmacokinet
pk
pk
specif
popul
renal
impair
hepat
impair
elderli
children
food
effect
popul
pk
importantli
data
human
physiolog
extrem
valuabl
construct
system
pharmacolog
model
access
data
drug
fda
pubm
book
commerci
product
larg
compil
approv
drug
dose
regimen
associ
pharmacokinet
absorpt
distribut
metabol
excret
avail
howev
physicochem
properti
aqueou
solubl
ph
profil
readili
avail
commerci
sourc
concert
effort
compil
curat
gener
data
product
way
achiev
common
goal
drug
repurpos
search
pubm
use
key
word
fdaapprov
drug
drug
repurpos
identifi
hundr
public
drug
repurpos
exampl
includ
doxapram
amoxapin
trifluoperazin
potenc
respiratori
gastrointestin
tract
bacteri
pathogen
amodiaquin
chloroquin
parkinson
diseas
activ
nuclear
receptorerel
protein
import
maintain
dopamin
neuron
lansoprazol
kill
mycobacterium
tuberculosi
inhibit
cytochrom
deplet
atp
need
tuberculosi
surviv
find
use
inclus
construct
pharmacodynam
diseas
biolog
databas
drug
repurpos
anoth
worthwhil
pharmacodynam
databas
communityconsensu
databas
specif
tackl
infecti
diseas
includ
neglect
tropic
diseas
infecti
diseas
share
common
featur
viru
use
gain
entri
host
cell
via
specif
protein
host
cell
protein
function
use
viru
replic
subsequ
infect
therefor
path
tackl
viral
diseas
one
target
viral
enzym
target
human
function
requir
viral
entri
replic
host
cell
protein
primari
target
control
treatment
infect
illustr
use
databas
zika
viru
diseas
discuss
herein
zika
viru
diseas
emerg
public
health
issu
associ
microcephali
newborn
prematur
birth
blind
newborn
neurolog
disord
elderli
vulner
popul
transmit
via
mosquito
bite
sexual
entri
zika
viru
human
cell
mainli
mediat
dendrit
cellspecif
intracellular
adhes
molecul
nonintegrin
dcsign
axl
receptor
tyrosin
kinas
protein
tyrosin
kinas
protein
also
receptor
flaviviru
entri
human
cell
protein
tyrosin
kinas
also
human
protein
entri
ebola
marburg
virus
http
wwwncbinlm
nihgovgen
abund
brain
rat
brain
wide
express
throughout
develop
stage
birth
compar
axl
receptor
tyrosin
kinas
play
key
role
matur
develop
central
nervou
system
therebi
constitut
potenti
target
battl
zika
viru
databas
knowledg
base
pharmacodynam
across
approv
drug
individu
antivir
potenc
foundat
conduct
system
pharmacolog
analysi
well
construct
system
pharmacolog
framework
model
battl
infecti
diseas
zika
viru
diseas
system
pharmacolog
analysi
integr
gene
express
protein
network
drug
target
facilit
drug
repurpos
hand
candid
identifi
next
step
would
use
exist
data
knowledg
drug
along
knowledg
human
biolog
conduct
quantit
system
pharmacolog
model
select
best
candid
candid
pair
develop
illustr
figur
system
pharmacolog
model
translat
tool
construct
design
captur
inform
transmiss
across
select
level
human
bodi
hierarchi
vitro
vivo
pharmacodynam
data
critic
need
enabl
translat
inform
transmiss
via
system
pharmacolog
model
drug
repurpos
clinic
marker
measur
treatment
either
publish
clinic
trial
ehr
incorpor
pharmacodynam
databas
system
pharmacolog
approach
meaning
infer
drug
diseas
interact
model
revers
diseas
biolog
tremend
medic
need
treat
control
cd
ncd
worldwid
emerg
infecti
diseas
neglect
tropic
diseas
longer
local
health
issu
preemptiv
control
spread
global
avail
big
data
rang
omic
readout
imag
biochem
phenotyp
clinic
laboratori
phenotyp
profil
individu
natur
diseas
medic
record
popul
respons
prescrib
treatment
regimen
across
ethic
group
present
new
opportun
frontier
drug
repurpos
humaninduc
pluripot
stem
cell
specif
organ
cell
type
deriv
humaninduc
pluripot
stem
cell
cancer
stem
cell
activ
investig
use
life
scienc
research
highthroughput
screen
technolog
appli
facilit
use
cell
screen
new
chemic
entiti
fingerprint
individu
market
drug
deciph
pharmacolog
network
drug
context
human
biolog
abil
discov
mode
action
approv
drug
system
pharmacolog
perspect
increas
fast
pace
advanc
informat
omic
technolog
transcriptom
proteom
metabolom
genom
abil
use
big
data
informat
technolog
need
databas
translat
action
drug
molecular
level
respons
phenotyp
observ
either
cell
cultur
construct
anim
human
databas
pharmacodynam
connect
clinic
marker
end
point
context
human
biolog
aid
use
system
pharmacolog
method
facilit
drug
repurpos
wake
global
health
burden
improv
global
wellb
pharmacodynam
databas
dedic
neglect
tropic
diseas
benefit
well
improv
global
economi
wellb
figur
system
pharmacolog
framework
drug
repurpos
pharmacodynam
need
translat
across
hierarchi
human
biolog
initi
evidencebas
drug
repurpos
origin
realworld
pharmacodynam
evid
dosedepend
pharmacodynam
measur
cell
organ
organsonthechip
preclin
organ
vitropreclin
pharmacodynamicphenotyp
measur
transmit
inform
molecularlevel
cell
communitylevel
interact
reveal
interact
drug
human
bodi
subject
level
target
diseas
popul
pharmacodynam
reflect
repurpos
therapeut
effect
drug
associ
popul
variabl
ultim
exist
biopharmaceut
clinic
pharmacolog
characterist
success
drug
repurpos
facilit
system
pharmacolog
model
pharmacodynam
respons
